NM-0822

Our research focuses on the development of new drugs for the treatment of colon cancer, metabolic and neurodegenerative diseases.

VIEW FEATURES

NM-0822

Therapeutic area

Carrier

Target disease

Biomimetic drug transporter that increases drug activity and decreases side effects

Study phase

Preclinical: In vitro

100%

Preclinical: In vivo

100%

Clinic I

Not initiated

Clinic II

Not initiated

Clinic III

Not initiated

Patent No.

Not applicable

Discover the Future

We are a biotechnology company committed to the discovery of efficient and effective bioactive principles as pharmaceuticals, nutraceuticals or useful in the field of plant biology.